ArticleThe Pan African medical journal2019
[A case study of bilateral cystic basal cell carcinoma in an albino].
Article in The Pan African medical journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 2 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Basal cell carcinoma is the most common skin cancer. It occurs in young adults older than 50 years and it is often caused by chronic exposure to solar rays, which explains why it often affects the face. In patient who are not treated immediately, the tumour develops slowly, with locoregional extension, but it rarely metastasizes. We here report a very rare case of bilateral cystic basal cell carcinoma in an albino young adult aged 36 years. The patient had terebrant left brachial ulcero-budding infiltrating mass with bone erosion (pathological fracture of the humerus) evolving over the last 7 years as well as ulcero-budding secondarily infected mass in the cervicodorsal junction evolving over the last 6 months. During his 1 month stay in our hospital, he underwent transfusion of 6 units of isogroup isoRh 450cc and boric acid dressings were applied as a complement to antibiotic therapy and iron therapy. Given the poor general health of the patient (cachexia, chronic anemia, development of the cancerous lesions), amputation of the left upper member and cervicodorsal mass excision were controindicated. Multidisciplinary team opted for second line treatment, including chemotherapy and/or radiotherapy. Given the lack technical equipment, the patient was transferred out to Lusaka.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.